Published in PLoS One on August 25, 2014
Fragile X Mental Retardation Protein expression in the retina is regulated by light. Exp Eye Res (2015) 0.75
The components of the retinal action potential in mammals and their relation to the discharge in the optic nerve. J Physiol (1933) 16.14
Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18
The mGluR theory of fragile X mental retardation. Trends Neurosci (2004) 8.88
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell (1994) 4.43
Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med (2010) 4.15
A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol (1992) 4.10
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology (2005) 4.09
Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74
Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci (2007) 3.31
The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev (2002) 3.26
Sensory Experiences Questionnaire: discriminating sensory features in young children with autism, developmental delays, and typical development. J Child Psychol Psychiatry (2006) 3.15
The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet (2007) 2.85
The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci U S A (2003) 2.82
Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci (2001) 2.64
A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci (2007) 2.54
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet (2008) 2.20
Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci (2008) 2.10
Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philos Trans R Soc Lond B Biol Sci (2009) 2.09
Sensory processing subtypes in autism: association with adaptive behavior. J Autism Dev Disord (2009) 2.08
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev (2001) 1.92
Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci U S A (2008) 1.91
Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet (2002) 1.76
Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice. J Biol Chem (2004) 1.64
Social behavior deficits in the Fmr1 mutant mouse. Behav Brain Res (2005) 1.54
The prenatal development of the mouse eye. Anat Rec (1970) 1.52
Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell (2012) 1.48
GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. PLoS One (2010) 1.47
Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron (2010) 1.46
Differential translation and fragile X syndrome. Genes Brain Behav (2005) 1.46
Synaptogenesis: a balancing act between excitation and inhibition. Curr Biol (2005) 1.45
Fmr1 KO mice as a possible model of autistic features. ScientificWorldJournal (2006) 1.40
Signals, synapses, and synthesis: how new proteins control plasticity. Front Neural Circuits (2009) 1.31
Expression of pain in children with autism. Clin J Pain (2004) 1.28
Ubiquitin homeostasis is critical for synaptic development and function. J Neurosci (2011) 1.26
Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proc Natl Acad Sci U S A (2011) 1.26
FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb Cortex (2000) 1.21
A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Res (2011) 1.16
Differential impact of the FMR1 gene on visual processing in fragile X syndrome. Brain (2004) 1.13
Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype. J Biol Chem (2011) 1.09
G-protein cascades: gain and kinetics. Trends Neurosci (1992) 1.06
Transport of truncated rhodopsin and its effects on rod function and degeneration. Invest Ophthalmol Vis Sci (2007) 1.06
Rhodopsin gene expression determines rod outer segment size and rod cell resistance to a dominant-negative neurodegeneration mutant. PLoS One (2012) 1.00
Fragile x syndrome and autism: from disease model to therapeutic targets. J Neurodev Disord (2009) 0.98
Caspase-dependent apoptosis in light-induced retinal degeneration. Invest Ophthalmol Vis Sci (2007) 0.95
Sensory processing correlates of occupational performance in children with fragile X syndrome: preliminary findings. Am J Occup Ther (2002) 0.94
Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice. Neurobiol Learn Mem (2011) 0.93
Incidence of significantly altered pain experience among individuals with developmental disabilities. Am J Ment Retard (1994) 0.93
Physiology of the retina. Annu Rev Neurosci (1979) 0.92
The rhodopsin content of human eyes. Invest Ophthalmol Vis Sci (1999) 0.90
Resolution of spatial and temporal visual attention in infants with fragile X syndrome. Brain (2011) 0.89
Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation. Epilepsia (2012) 0.89
Chemical probing of the light-induced interaction between rhodopsin and G-protein. Near-infrared light-scattering and sulfhydryl modifications. J Biol Chem (1985) 0.83
Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain. Neuropathology (2010) 0.82
Age-related changes in retinal sensitivity, rhodopsin content and rod outer segment length in hooded rats following low-level lead exposure during development. Exp Eye Res (1989) 0.81
Mouse embryonic retina delivers information controlling cortical neurogenesis. PLoS One (2010) 0.81
Sensory impairment in mental retardation: a potential role for NGF. Arch Ital Biol (2011) 0.78
Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice. J Neurochem (2012) 0.78
Combined deletion of two Condensin II system genes (NCAPG2 and MCPH1) in a case of severe microcephaly and mental deficiency. Eur J Med Genet (2013) 0.78
FMRP: a triple threat to PSD-95. Front Cell Neurosci (2013) 0.77
Calpains are activated by light but their inhibition has no neuroprotective effect against light-damage. Exp Eye Res (2009) 0.75